1 |
Manan FAA, Yusof NA, Abdullah J, Nurdin A. Central Composite Design for Optimization of Mitomycin C-Loaded Quantum Dots/Chitosan Nanoparticles as Drug Nanocarrier Vectors. Pharmaceutics 2023;15. [PMID: 36678837 DOI: 10.3390/pharmaceutics15010209] [Reference Citation Analysis]
|
2 |
Chhillar M, kukkar D, Kukkar P, Kim K. Nanoparticle-antibody conjugate-based immunoassays for detection of CKD-associated biomarkers. TrAC Trends in Analytical Chemistry 2022. [DOI: 10.1016/j.trac.2022.116857] [Reference Citation Analysis]
|
3 |
Panda S, Hajra S, Kaushik A, Rubahn H, Mishra Y, Kim H. Smart nanomaterials as the foundation of a combination approach for efficient cancer theranostics. Materials Today Chemistry 2022;26:101182. [DOI: 10.1016/j.mtchem.2022.101182] [Reference Citation Analysis]
|
4 |
Coluccia M, Parisse V, Guglielmi P, Giannini G, Secci D. Metal-organic frameworks (MOFs) as biomolecules drug delivery systems for anticancer purposes. European Journal of Medicinal Chemistry 2022;244:114801. [DOI: 10.1016/j.ejmech.2022.114801] [Reference Citation Analysis]
|
5 |
Zoulikha M, He W. Targeted Drug Delivery for Chronic Lymphocytic Leukemia. Pharm Res. [DOI: 10.1007/s11095-022-03214-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
6 |
Sarawagi N, Vaid K, Dhiman J, Johns T, Kumar V. Nanomaterials-Based Immunosensors in Food Analysis. Nanosensing and Bioanalytical Technologies in Food Quality Control 2022. [DOI: 10.1007/978-981-16-7029-9_11] [Reference Citation Analysis]
|
7 |
Manan FAA, Yusof NA, Abdullah J, Mohammad F, Nurdin A, Yazan LS, Khiste SK, Al-Lohedan HA. Drug Release Profiles of Mitomycin C Encapsulated Quantum Dots-Chitosan Nanocarrier System for the Possible Treatment of Non-Muscle Invasive Bladder Cancer. Pharmaceutics 2021;13:1379. [PMID: 34575455 DOI: 10.3390/pharmaceutics13091379] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|